Winton Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,793
| Closed | -$816K | – | 992 |
|
|
2025
Q1 | $816K | Buy |
12,793
+7,213
| +129% | +$460K | 0.05% | 461 |
|
|
2024
Q4 | $678K | Buy |
+5,580
| New | +$678K | 0.05% | 418 |
|
|
2024
Q3 | – | Sell |
-2,688
| Closed | -$425K | – | 761 |
|
|
2024
Q2 | $425K | Buy |
+2,688
| New | +$425K | 0.03% | 444 |
|
|
2023
Q3 | – | Sell |
-2,823
| Closed | -$323K | – | 919 |
|
|
2023
Q2 | $323K | Sell |
2,823
-3,342
| -54% | -$383K | 0.03% | 502 |
|
|
2023
Q1 | $850K | Sell |
6,165
-6,732
| -52% | -$928K | 0.05% | 499 |
|
|
2022
Q4 | $1.67M | Buy |
+12,897
| New | +$1.67M | 0.11% | 246 |
|
|
2022
Q1 | – | Sell |
-10,430
| Closed | -$939K | – | 1134 |
|
|
2021
Q4 | $939K | Buy |
+10,430
| New | +$939K | 0.06% | 480 |
|
|
2021
Q2 | – | Sell |
-4,664
| Closed | -$348K | – | 1510 |
|
|
2021
Q1 | $348K | Sell |
4,664
-847
| -15% | -$63.2K | 0.02% | 1077 |
|
|
2020
Q4 | $940K | Sell |
5,511
-27,895
| -84% | -$4.76M | 0.07% | 438 |
|
|
2020
Q3 | $4.69M | Sell |
33,406
-7,825
| -19% | -$1.1M | 0.15% | 137 |
|
|
2020
Q2 | $6.61M | Buy |
41,231
+4,909
| +14% | +$787K | 0.17% | 128 |
|
|
2020
Q1 | $3.55M | Buy |
36,322
+17,036
| +88% | +$1.67M | 0.09% | 380 |
|
|
2019
Q4 | $2.49M | Buy |
19,286
+9,162
| +90% | +$1.18M | 0.03% | 719 |
|
|
2019
Q3 | $763K | Buy |
10,124
+5,552
| +121% | +$418K | 0.01% | 946 |
|
|
2019
Q2 | $695K | Sell |
4,572
-2,999
| -40% | -$456K | 0.01% | 539 |
|
|
2019
Q1 | $902K | Sell |
7,571
-2,802
| -27% | -$334K | 0.02% | 367 |
|
|
2018
Q4 | $1.13M | Buy |
10,373
+4,578
| +79% | +$500K | 0.02% | 331 |
|
|
2018
Q3 | $936K | Sell |
5,795
-431
| -7% | -$69.6K | 0.02% | 417 |
|
|
2018
Q2 | $823K | Sell |
6,226
-4,765
| -43% | -$630K | 0.02% | 490 |
|
|
2018
Q1 | $814K | Buy |
+10,991
| New | +$814K | 0.02% | 586 |
|